UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The inhibition of monoamine oxidase by esomeprazole

Drug research (Stuttgart), 2013-09, Vol.63 (9), p.462

2013

Volltextzugriff (PDF)

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease

Experimental neurology, 2003-11, Vol.184 (1), p.285-294

2003

Volltextzugriff (PDF)

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease

The Journal of neuroscience, 2001-05, Vol.21 (10), p.RC143

2001

Volltextzugriff (PDF)

Synthesis and Antimonoamine Oxidase Activity of 2-(3-Iminoisoindol-1-ylidene)-2-arylacetonitriles

Russian journal of organic chemistry, 2022-05, Vol.58 (5), p.663-668

2022

Volltextzugriff (PDF)

The inhibition of monoamine oxidase by phenformin and pentamidine

Drug research, 2014-09, Vol.64 (9), p.454-461

2014

Volltextzugriff (PDF)

The inhibition of acetylcholinesterase by dantrolene and ondansetron

Drug research, 2015-01, Vol.65 (1), p.46-51

2015

Volltextzugriff (PDF)

Caffeine as a lead compound for the design of therapeutic agents for the treatment of Parkinson's disease

Current medicinal chemistry, 2015-01, Vol.22 (8), p.975-988

2015

Volltextzugriff (PDF)

The inhibition of monoamine oxidase by 8-(2-phenoxyethoxy)caffeine analogues

Arzneimittel-Forschung, 2012-11, Vol.62 (11), p.513-518

2012

Volltextzugriff (PDF)

Neuroprotection in the MPTP Parkinsonian C57BL/6 Mouse Model by a Compound Isolated from Tobacco

Chemical research in toxicology, 2001-05, Vol.14 (5), p.523-527

2001

Volltextzugriff (PDF)

Phase 2 Enzyme Induction by the Major Metabolite of Oltipraz

Chemical research in toxicology, 2003-11, Vol.16 (11), p.1463-1469

2003

Volltextzugriff (PDF)

2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors

Drug design, development and therapy, 2015-01, Vol.9 (default), p.3635-3644

2015

Volltextzugriff (PDF)

3-Coumaranone derivatives as inhibitors of monoamine oxidase

Drug design, development and therapy, 2015-01, Vol.9 (default), p.5479-5489

2015

Volltextzugriff (PDF)

Inhibition of Nitric Oxide Synthase by L-NAME Promotes Cisplatin-Induced Nephrotoxicity in Male Rats

ISRN toxicology, 2013-09, Vol.2013, p.1-6

2013

Volltextzugriff (PDF)

Metabolic defects caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and by HPTP (the tetrahydropyridinyl analog of haloperidol), in rats

Life sciences (1973), 2000-04, Vol.66 (20), p.1949

2000

Volltextzugriff (PDF)

Validation of the Dynamic Direct Exposure Method for Toxicity Testing of Diesel Exhaust In Vitro

ISRN toxicology, 2013-08, Vol.2013, p.1-11

2013

Volltextzugriff (PDF)

Rational approaches towards reversible inhibition of type B monoamine oxidase. Design and evaluation of a novel 5H-Indeno[1,2- c]pyridazin-5-one derivative

Bioorganic & medicinal chemistry letters, 2003-01, Vol.13 (1), p.69-73

2003

Volltextzugriff (PDF)

8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A sub(2A) Receptor Antagonism

The Journal of biological chemistry, 2002-09, Vol.277 (39), p.36040-36044

2002

Volltextzugriff (PDF)

Neuroprotection by Caffeine and A sub(2A) Adenosine Receptor Inactivation in a Model of Parkinson's Disease

The Journal of neuroscience, 2001-05, Vol.21 (10)

2001

Volltextzugriff (PDF)

(E)-8-(3-Chlorostyryl)-1,3,7-trimethylxanthine, a caffeine derivative acting both as antagonist of adenosine A2A receptors and as inhibitor of MAO-B

Acta crystallographica. Section C, Crystal structure communications, 2005-09, Vol.61 (9), p.o531-o532

2005

Volltextzugriff (PDF)

The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase

Bioorganic & medicinal chemistry letters, 2022-07, Vol.67, p.128746-128746, Article 128746

2022

Volltextzugriff (PDF)

Synthesis and evaluation of 3-hydroxyquinolin-2(1H)-one derivatives as inhibitors of tyrosinase

Bioorganic & medicinal chemistry letters, 2024-09, Vol.109, p.129823, Article 129823

2024

Volltextzugriff (PDF)

Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives

European journal of medicinal chemistry, 2012-03, Vol.49, p.343-353

2012

Volltextzugriff (PDF)

Selected chromone derivatives as inhibitors of monoamine oxidase

Bioorganic & medicinal chemistry letters, 2012-09, Vol.22 (17), p.5480-5484

2012

Volltextzugriff (PDF)

Methylene blue analogues: In vitro antimicrobial minimum inhibitory concentrations and in silico pharmacophore modelling

European journal of pharmaceutical sciences, 2021-02, Vol.157, p.105603-105603, Article 105603

2021

Volltextzugriff (PDF)

α-Tetralone derivatives as inhibitors of monoamine oxidase

Bioorganic & medicinal chemistry letters, 2014-06, Vol.24 (12), p.2758-2763

2014

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(160)
Mit Volltextzugriff
(147)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The inhibition of monoamine oxidase by esomeprazole

A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease

Neuroprotection by caffeine and A(2A) adenosine receptor inactivation in a model of Parkinson's disease

Synthesis and Antimonoamine Oxidase Activity of 2-(3-Iminoisoindol-1-ylidene)-2-arylacetonitriles

The inhibition of monoamine oxidase by phenformin and pentamidine

The inhibition of acetylcholinesterase by dantrolene and ondansetron

Caffeine as a lead compound for the design of therapeutic agents for the treatment of Parkinson's disease

The inhibition of monoamine oxidase by 8-(2-phenoxyethoxy)caffeine analogues

Neuroprotection in the MPTP Parkinsonian C57BL/6 Mouse Model by a Compound Isolated from Tobacco

Phase 2 Enzyme Induction by the Major Metabolite of Oltipraz

2-acetylphenol analogs as potent reversible monoamine oxidase inhibitors

3-Coumaranone derivatives as inhibitors of monoamine oxidase

Inhibition of Nitric Oxide Synthase by L-NAME Promotes Cisplatin-Induced Nephrotoxicity in Male Rats

Metabolic defects caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and by HPTP (the tetrahydropyridinyl analog of haloperidol), in rats

Validation of the Dynamic Direct Exposure Method for Toxicity Testing of Diesel Exhaust In Vitro

Rational approaches towards reversible inhibition of type B monoamine oxidase. Design and evaluation of a novel 5H-Indeno[1,2- c]pyridazin-5-one derivative

8-(3-Chlorostyryl)caffeine May Attenuate MPTP Neurotoxicity through Dual Actions of Monoamine Oxidase Inhibition and A sub(2A) Receptor Antagonism

Neuroprotection by Caffeine and A sub(2A) Adenosine Receptor Inactivation in a Model of Parkinson's Disease

(E)-8-(3-Chlorostyryl)-1,3,7-trimethylxanthine, a caffeine derivative acting both as antagonist of adenosine A2A receptors and as inhibitor of MAO-B

The evaluation of N-propargylamine-2-aminotetralin as an inhibitor of monoamine oxidase

Synthesis and evaluation of 3-hydroxyquinolin-2(1H)-one derivatives as inhibitors of tyrosinase

Inhibition of monoamine oxidase by selected C6-substituted chromone derivatives

Selected chromone derivatives as inhibitors of monoamine oxidase

Methylene blue analogues: In vitro antimicrobial minimum inhibitory concentrations and in silico pharmacophore modelling

α-Tetralone derivatives as inhibitors of monoamine oxidase

Suchergebnisse filtern